Roundup (herbicide)

From WikiMD's WELLNESSPEDIA

Roundup is a brand of herbicide primarily used in agriculture and gardening. It is produced by the American company Monsanto, which is now owned by Bayer. The active ingredient in Roundup is glyphosate, a broad-spectrum systemic herbicide and crop desiccant.

Roundup

History[edit]

Roundup was first introduced by Monsanto in 1974. The patent for glyphosate expired in 2000, leading to the production of similar products by other companies.

Usage[edit]

Roundup is used to kill weeds, especially annual broadleaf weeds and grasses that compete with crops. It is absorbed through foliage and minimally through roots, meaning that it is only effective on actively growing plants and not effective as a pre-emergence herbicide.

Health and environmental effects[edit]

There is ongoing debate about the safety of Roundup, with some studies suggesting potential health risks to humans and negative environmental impacts. The International Agency for Research on Cancer (IARC), a branch of the World Health Organization, classified glyphosate as "probably carcinogenic in humans" in 2015. However, other regulatory bodies, including the European Food Safety Authority (EFSA) and the United States Environmental Protection Agency (EPA), have stated that glyphosate is unlikely to pose a carcinogenic risk to humans.

Legal issues[edit]

Monsanto has faced numerous lawsuits over alleged health effects from Roundup. In 2018, a California jury awarded $289 million in damages to a man who alleged that his cancer was caused by exposure to Roundup.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.